课题基金 / 基金详情

Targeting Host and Apicomplexan Isoprenoid Pathways

Targeting Host and Apicomplexan Isoprenoid Pathways
靶向宿主和顶复类异戊二烯途径
批准号:
8890100
负责人:
Silvia N Moreno
金额:
$43.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2017-06-30

项目摘要

项目成果

Silvia N Moreno的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Apicomplexa are important pathogens that include the causative agents of malaria, toxoplasmosis, and cryptosporidiosis. Toxoplasma gondii is the causative agent of human toxoplasmosis, a systemic infection acquired mostly through contaminated water and vegetables, or uncooked meat. Tissue cyst formation occurs soon after infection and is responsible for lifelong infection in immunocompetent individuals. At least one-third of the World's population and about 22.5% of Americans are seropositive for toxoplasmosis, making it one of the most prevalent infections in the United States. T. gondii resides intracellularly within parasitophorous vacuoles, and reactivation and dissemination of infection to different organs may occur following immune suppression. Cryptosporidium parvum is responsible for significant disease burden among children in developing countries and it can result in chronic and life-threatening enteritis in AIDS patients. The present chemotherapy available against T. gondii chronic infection and cryptosporidiosis is not effective and new drugs are urgently needed to treat both infections. T. gondii lacks a mevalonate pathway for the synthesis of isoprenoid precursors but harbor a 1-deoxy-D- xylulose-5-phosphate (DOXP) pathway in its apicoplast. This pathway generates isopentenyl diphosphate (IPP) and dimethyallyl diphosphate (DMAPP), which are condensed by the action of a unique farnesyl diphosphate synthase (TgFPPS) into farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP). Our preliminary data have indicated that the DOXP pathway is essential for T. gondii survival in its host. Surprisingly, though, drugs acting on the mevalonate pathway, like statins, are active in vitro and in vivo against the parasite. These results indicate that the parasite needs to synthesize some isoprenoid precursors (IPP, DMAPP), while salvaging others (FPP, GGPP) from its host. We will exploit this to develop a double hit strategy. Remarkably the model suggests that Cryptosporidium parvum should be highly susceptible to this approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of polyphosphate in Toxoplasma gondii
  • 批准号:
    10681078
  • 项目类别:
  • 资助金额:
    $21.28万
  • 财政年份:
    2023
  • 负责人:
    Silvia N Moreno
  • 依托单位:
Divergent Calcium Channels of the Apicomplexan parasite Toxoplasma gondii
  • 批准号:
    10681807
  • 项目类别:
  • 资助金额:
    $62.48万
  • 财政年份:
    2023
  • 负责人:
    Silvia N Moreno
  • 依托单位:
Validation of the ubiquinone synthesis pathway of Toxoplasma gondii as a novel drug target
  • 批准号:
    10707505
  • 项目类别:
  • 资助金额:
    $43.11万
  • 财政年份:
    2022
  • 负责人:
    Silvia N Moreno
  • 依托单位:
Validation of the ubiquinone synthesis pathway of Toxoplasma gondii as a novel drug target
  • 批准号:
    10608408
  • 项目类别:
  • 资助金额:
    $41.57万
  • 财政年份:
    2022
  • 负责人:
    Silvia N Moreno
  • 依托单位:
海外基金